Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Angiographic and Psychosocial Evaluation of Peripartum vs. Non: SCAD (SCAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03390998
Recruitment Status : Enrolling by invitation
First Posted : January 5, 2018
Last Update Posted : August 31, 2018
Sponsor:
Collaborators:
Massachusetts General Hospital
Mayo Clinic
University Hospital, Clermont-Ferrand
University of British Columbia
University of Leicester
Vanderbilt University Medical Center
Information provided by (Responsible Party):
Katharine Sears Edwards, Stanford University

Brief Summary:
This multi-site international clinical research project is a collaboration between investigators from multiple institutions in the USA, Canada, and Europe. Approximately 7 to 11 sites will participate and provide data for analysis. Clinical operations (for data collection and analysis) across sites will be managed by Stanford. The study purpose is to determine differences in clinical and imaging presentation, in-hospital management and prognosis in peripartum and non-peripartum SCAD patients.

Condition or disease
Spontaneous Coronary Artery Dissection

Detailed Description:

There is a reason to believe that female sex hormone fluctuations during the peripartum period are linked with the occurrence of SCAD, and may be associated with a distinctive clinical presentation. In addition, symptoms of psychological distress may be linked to the development of SCAD and post-event distress is higher in SCAD patients than in those with coronary artery disease (CAD).

The primary objective is to determine differences in clinical and imaging presentation, in-hospital management and prognosis in peri-partum and non-peri-partum SCAD patients. At the methodological level, the purpose is to apply a systematic image analysis protocol for classifying SCAD lesions and to pool data to achieve adequate statistical power.

The secondary objective is to gather more information about psychological and psychosocial factors in SCAD patients. Specifically, to assess pre-event stress and psychological diagnoses and determine differences in post-event distress between peripartum and non-peripartum SCAD.

It is expected that these aims will result in two important outcomes. First, implementation of a systematic image analysis protocol for SCAD data will lead to improved reliability and, we expect, the detection of clinically meaningful differences between peripartum and non-peripartum SCAD. These differences may align with potential causal mechanisms for further study to ultimately better understand SCAD and develop treatment(s). Second, by characterizing the psychological distress experienced by SCAD patients, and differences between patients who experienced peripartum vs. non-peripartum SCAD, psychosocial risk factors may be identified and psychosocial interventions can be tailored to meet the needs of this unique patient population.

This is an observational study using cross-sectional design. There are two main components: a retrospective collection of medical history pertaining to SCAD event and prospective questionnaires. Sites may elect not to contact patients and not collect the prospective questionnaire.

Clinical variables will include demographic data, cardiac risk factors, medications and details of presentation (including peak troponin, left ventricular ejection fraction (LVEF), and days to discharge), as well as follow-up data, including recurrent events, and symptoms of depression, anxiety, stress, and PTSD.

Clinical data will be obtained by study collaborators and entered into a secure database maintained on Stanford systems. De-identified imaging data will be uploaded by collaborators. Imaging data will be analyzed by two independent readers (selected from participating institutions).


Layout table for study information
Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Angiographic and Psychosocial Evaluation of Peripartum vs. Non Peripartum Spontaneous Coronary Artery Dissection (SCAD): A Collaborative Study
Actual Study Start Date : November 28, 2017
Estimated Primary Completion Date : May 31, 2019
Estimated Study Completion Date : August 31, 2019

Resource links provided by the National Library of Medicine


Group/Cohort
Peripartum SCAD
Female patients who experienced any SCAD event that occurred during pregnancy or up to 1 year post-delivery
Non-peripartum SCAD
Female patients who experienced any SCAD with event onset outside of the pregnancy period



Primary Outcome Measures :
  1. First Major Adverse Cardiovascular Event (post-SCAD) [ Time Frame: First SCAD event represents t=0. Time (in days) from t=0 until the first occurrence of any of the above, for up to 6-months after t=0. ]
    The time from the first SCAD event until the first occurrence of (1) myocardial infarction, (2) re-vascularization, (3) stroke, or (4) death due to cardiovascular cause.


Secondary Outcome Measures :
  1. Depression [ Time Frame: At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD. ]
    Patient Health Questionnaire (PHQ9) is a 9-item questionnaire that measures depression on a scale of 0-27 (where >20 is major depression).

  2. Anxiety [ Time Frame: At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD. ]
    Generalized Anxiety Disorder (GAD-7) is a 7-item questionnaire that measures anxiety on a scale of 0-21 (where >14 is severe anxiety).

  3. Stress [ Time Frame: At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD. ]
    Perceived Stress Scale (PSS) is a 10-item questionnaire that measures stress on a scale of 0-40 (where >26 is high perceived stress).

  4. Post-Traumatic Stress Disorder [ Time Frame: At survey administration (post-SCAD), ranging from 6-months to 10 years post SCAD. ]
    PTSD CheckList (PCL-5) is a 20-item questionnaire that assesses the presence and severity of PTSD symptoms on a scale of 0-80 (where >32 suggests the patients needs further assessment to confirm a diagnosis of PTSD).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Only women will be studied as the primary question relates to pregnancy-related SCAD
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants with pregnancy-related and non pregnancy-related SCAD will be recruited from the population of SCAD patients known to an international collaborative of investigators. We expect to enroll approximately 400 patients, 100 of whom have experienced peripartum SCAD. For each enrolled participant with peripartum SCAD, we will enroll 3 patients with non-peripartum SCAD who are the closest match on age at SCAD event and country.
Criteria

Inclusion Criteria:

Sites contacting patients and/or conducting the survey

  • Female adults 18 years of age and older
  • Voluntary participation
  • Patients with a known or suspected diagnosis of SCAD
  • Ability to read in English
  • Ability to access online consent and questionnaire portal

Sites not contacting patients and/or conducting the survey

  • Female adults 18 years of age and older
  • Patients with a known or suspected diagnosis of SCAD

Exclusion Criteria

- Not fulfilling inclusion criteria


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03390998


Locations
Layout table for location information
United States, California
Stanford University Medical Center
Palo Alto, California, United States, 94305
Sponsors and Collaborators
Katharine Sears Edwards
Massachusetts General Hospital
Mayo Clinic
University Hospital, Clermont-Ferrand
University of British Columbia
University of Leicester
Vanderbilt University Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Jennifer Ann Tremmel, MD, MS Stanford University
Principal Investigator: Katharine S. Edwards, PhD Stanford University

Layout table for additonal information
Responsible Party: Katharine Sears Edwards, Clinical Assistant Professor, Medicine - Cardiovascular Medicine, Stanford University
ClinicalTrials.gov Identifier: NCT03390998     History of Changes
Other Study ID Numbers: 40486
First Posted: January 5, 2018    Key Record Dates
Last Update Posted: August 31, 2018
Last Verified: August 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Katharine Sears Edwards, Stanford University:
Pregnancy-related SCAD
Myocardial Infarction

Additional relevant MeSH terms:
Layout table for MeSH terms
Aneurysm, Dissecting
Aneurysm
Vascular Diseases
Cardiovascular Diseases